Skip to search formSkip to main contentSkip to account menu

Flecainide Acetate

Known as: Flecainide Acetate [Chemical/Ingredient], Acetate, Flecainide, Flecainide Monoacetate 
The acetate salt form of flecainide, a synthetic agent derived from trifluoroethoxy-benzamide exhibiting antiarrhythmic and local anesthetic activity… 
National Institutes of Health

Related topics

Related topics

14 relations
AmprenavirAnti-Arrhythmia AgentsBundle-Branch BlockCoronary heart disease

Narrower (2)

R818Tambocor

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2011
Review
2011
Comparison of Transplacental Treatment of Fetal Supraventricular Tachyarrhythmias With Digoxin, Flecainide, and Sotalol: Results of a Nonrandomized Multicenter Study
Background— Fetal tachyarrhythmia may result in low cardiac output and death. Consequently, antiarrhythmic treatment is offered… 
Highly Cited
1996
Highly Cited
1996
Prospective comparison of flecainide versus quinidine for the treatment of paroxysmal atrial fibrillation/flutter. The Flecainide Multicenter Atrial Fibrillation Study Group.
Highly Cited
1996
Highly Cited
1996
Safety of long-term flecainide and propafenone in the management of patients with symptomatic paroxysmal atrial fibrillation: report from the Flecainide and Propafenone Italian Study Investigators.
Highly Cited
1994
Highly Cited
1994
Interaction of Baseline Characteristics With The Hazard of Encainide, Flecainide, and Moricizine Therapy in Patients With Myocardial Infarction: A Possible Explanation for Increased Mortality in the…
BackgroundThe Cardiac Arrhythmia Suppression Trial (CAST) was designed to test the hypothesis that suppression of ventricular… 
Highly Cited
1989
Highly Cited
1989
Intravenous flecainide versus verapamil for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm.
Highly Cited
1989
Highly Cited
1989
Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.
Flecainide acetate has a recognized proarrhythmic effect in patients treated for ventricular tachycardia. Three patients… 
Highly Cited
1989
Highly Cited
1989
Reversal of proarrhythmic effects of flecainide acetate and encainide hydrochloride by propranolol.
The use of membrane-active antiarrhythmic agents may be complicated by aggravation of existing arrhythmias or development of new… 
Highly Cited
1988
Highly Cited
1988
Acute conversion of atrial fibrillation to sinus rhythm: clinical efficacy of flecainide acetate. Comparison of two regimens.
The efficacy and safety of oral (up to 400 mg in 3 h) and intravenous regimens (up to 150 mg in 10 min) of flecainide acetate… 
Highly Cited
1986
Highly Cited
1986
Classification by type of ventricular arrhythmia predicts frequency of adverse cardiac events from flecainide.
Highly Cited
1986
Highly Cited
1986
Pharmacodynamics and side effects of flecainide acetate
We compared side effects with flecainide trough levels and ECG intervals among 43 patients who received flecainide for up to 34… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)